British medical journal the Lancet recently released a study on made-in-India Bharat Biotech’s Covaxin and said that the vaccine doses were well tolerated and no vaccine-related serious adverse events were found. The study was, however, conducted during the phase 1 trial of the vaccine. The first face of the trial of Bharat Biotech’s Covaxin was...
Days after approving two vaccines for emergency use in India, the reports are that the world’s largest vaccination program will commence from January 13 in India. “We are prepared to roll out covid-19 vaccines within 10 days of granting emergency use authorization date, based on dry run feedback. But the government will only decide the...
After the announcement that the indigenous coronavirus vaccine COVAXIN would be out by 15th August, the human trials are set to be conducted. Indian Council of Medical Research (ICMR) has decided to start the human trails of COVAXIN and the country’s second potential drug against pandemic ZyCoV-D from this month. A total of 2,000 people would...
The first indigenous made coronavirus vaccine named “Covaxin” will be launched on 15 August 2020 if human trials of the vaccine are successful. The vaccine is being developed by the Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited. A dozen institutes have been selected for clinical trials of the indigenous...
